Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancy
about
Kinetics and determining factors of the virologic response to antiretrovirals during pregnancy.Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource SettingsAtazanavir pharmacokinetics with and without tenofovir during pregnancyReduced indinavir exposure during pregnancy.Pharmacokinetic optimization of antiretroviral therapy in pregnancy.HIV protease inhibitors in pregnancy : pharmacology and clinical use.
P2860
Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancy
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Antiretroviral therapy with a ...... nfected women during pregnancy
@ast
Antiretroviral therapy with a ...... nfected women during pregnancy
@en
type
label
Antiretroviral therapy with a ...... nfected women during pregnancy
@ast
Antiretroviral therapy with a ...... nfected women during pregnancy
@en
prefLabel
Antiretroviral therapy with a ...... nfected women during pregnancy
@ast
Antiretroviral therapy with a ...... nfected women during pregnancy
@en
P2093
P2860
P50
P356
P1476
Antiretroviral therapy with a ...... nfected women during pregnancy
@en
P2093
Anne-Geneviève Marcelin
Chantal Cornélie
Claire Pérot
Ines De Montgolfier
Jade Ghosn
Manuela Bonmarchand
Marc Dommergues
Michèle Pauchard
Rachid Agher
Roland Tubiana
P2860
P304
P356
10.1128/AAC.01301-07
P407
P577
2008-02-04T00:00:00Z